Tremfya 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FTWA9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,809
Award facts
- Contract value 100% obligated
- $21,809.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,809.10 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for TREMFYA 100 mg/ml syringes, with an ultimate completion date of August 4, 2025. This delivery order was issued without a set-aside designation and represents performance at the company's location in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been registered in the System for Award Management since 2001 and specializes in supplying comprehensive pharmaceutical products to federal healthcare systems.
This delivery order is issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The underlying IDC covers an extensive portfolio of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. TREMFYA, a prescription biologic medication, aligns with the company's established contract portfolio delivering specialized pharmaceutical products to military health facilities. As a consistently successful competitor in federal procurement, DMS Pharmaceutical Group leverages its woman-owned small business status to secure contracts across the Defense Logistics Agency's pharmaceutical supply network.
Quick answers
Who was awarded contract SPE2DB25FTWA9?
SPE2DB25FTWA9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FTWA9 worth?
The government has obligated $21,809 on SPE2DB25FTWA9.
Is contract SPE2DB25FTWA9 an order under another contract?
Yes. SPE2DB25FTWA9 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWA9 competed?
The extent of competition for SPE2DB25FTWA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award